Myasthenia Gravis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials
• Forums

Exercise in Autoimmune Myasthenia Gravis and Myasthenic Syndromes
Conditions:   Autoimmune Myasthenia Gravis;   Lambert-Eaton Myasthenic Syndrome;   Congenital Myasthenic Syndrome;   Myasthenia Gravis Intervention:   Sponsors:   Institut de Myologie, France;   Association Française contre les Myopathies (AFM), Paris Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2022 Category: Research Source Type: clinical trials

Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis
Condition:   Generalized Myasthenia Gravis Interventions:   Drug: Batoclimab 680 mg SC weekly;   Drug: Batoclimab 340 mg SC weekly;   Drug: Matching Placebo SC;   Drug: Batoclimab 340 mg SC bi-weekly Sponsor:   Immunovant Sciences GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials